\-\ Texto\\:\\ \ \(0\)\
\-\ hypertension\ \(298\)\
\-\ medical\\ control\\ of\\ blood\\ pressure\\.\ \(0\)\
\-\ ct\\ demonstrates\\ focal\\ high\\ density\\ in\\ the\\ region\\ of\\ the\\ left\\ putamen\\.\\ contrast\\ was\\ administered\\ due\\ to\\ apparent\\ vasogenic\\ edema\\ on\\ the\\ preceding\\ non\\-contrast\\ examination\\.\\ a\\ follow\\-up\\ mri\\ performed\\ 3\\ months\\ later\\ demonstrates\\ evidence\\ of\\ residual\\ blood\\ products\\ in\\ the\\ same\\ region\\.\\ note\\ the\\ decrease\\ in\\ mass\\ effect\\ on\\ the\\ follow\\-up\\ study\\.\ \(0\)\
\-\ hemorrhage\\ in\\ basal\\ ganglia\\,\\ hypertensive\\,\\ acute\\ stroke\ \(0\)\
\-\ hypertensive\\ hemorrhage\ \(2\)\
\-\ amyloid\\ angiopathy\\ \ \(1\)\
\-\ hemorrhagic\\ primary\\ or\\ metastatic\\ malignancy\ \(0\)\
\-\ 76\\ year\\-old\\ hypertensive\\ male\\ with\\ altered\\ mental\\ status\\,\\ presenting\\ to\\ the\\ emergency\\ department\\ via\\ ems\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hypertensive\\:\\ 0\\.4181216050895558\ \(0\)\
\-\ the\\:\\ 0\\.18745826261384138\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.17971388336961125\ \(0\)\
\-\ preceding\\:\\ 0\\.17676475235598482\ \(0\)\
\-\ putamen\\:\\ 0\\.1672251330651523\ \(0\)\
\-\ ems\\:\\ 0\\.1642803451927844\ \(0\)\
\-\ angiopathy\\:\\ 0\\.16293554511899974\ \(0\)\
\-\ region\\:\\ 0\\.16055667427768955\ \(0\)\
\-\ blood\\:\\ 0\\.15588805348429915\ \(0\)\
\-\ amyloid\\:\\ 0\\.1517146681868189\ \(0\)\
\-\ products\\:\\ 0\\.14190615915685006\ \(0\)\
\-\ administered\\:\\ 0\\.13889854722556016\ \(0\)\
\-\ altered\\:\\ 0\\.13623219569261652\ \(0\)\
\-\ demonstrates\\:\\ 0\\.1348512576904959\ \(0\)\
\-\ in\\:\\ 0\\.13354833815000014\ \(0\)\
\-\ vasogenic\\:\\ 0\\.1320127347613828\ \(0\)\
\-\ 76\\:\\ 0\\.1320127347613828\ \(0\)\
\-\ contrast\\:\\ 0\\.13041976710108358\ \(0\)\
\-\ ganglia\\:\\ 0\\.12613896036299702\ \(0\)\
\-\ stroke\\:\\ 0\\.12480936390595256\ \(0\)\
\-\ residual\\:\\ 0\\.1221245521162072\ \(0\)\
\-\ mental\\:\\ 0\\.11696696724051499\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.11641765989070386\ \(0\)\
\-\ decrease\\:\\ 0\\.11535608451416737\ \(0\)\
\-\ basal\\:\\ 0\\.114842734780069\ \(0\)\
\-\ control\\:\\ 0\\.11467407745506421\ \(0\)\
\-\ department\\:\\ 0\\.1135261621794804\ \(0\)\
\-\ apparent\\:\\ 0\\.11227937533472045\ \(0\)\
\-\ via\\:\\ 0\\.1096944812267806\ \(0\)\
\-\ same\\:\\ 0\\.10616502857767794\ \(0\)\
\-\ presenting\\:\\ 0\\.10513445816423171\ \(0\)\
\-\ hypertension\\:\\ 0\\.10268921339053706\ \(0\)\
\-\ pressure\\:\\ 0\\.1021896702918638\ \(0\)\
\-\ note\\:\\ 0\\.10103234209513554\ \(0\)\
\-\ malignancy\\:\\ 0\\.10047434923630308\ \(0\)\
\-\ emergency\\:\\ 0\\.09957279847450004\ \(0\)\
\-\ later\\:\\ 0\\.0960473065890363\ \(0\)\
\-\ effect\\:\\ 0\\.09414652963095817\ \(0\)\
\-\ status\\:\\ 0\\.09365997411513861\ \(0\)\
\-\ study\\:\\ 0\\.08950837833046253\ \(0\)\
\-\ density\\:\\ 0\\.08899502859636414\ \(0\)\
\-\ examination\\:\\ 0\\.08588158339899145\ \(0\)\
\-\ medical\\:\\ 0\\.08529580386088687\ \(0\)\
\-\ primary\\:\\ 0\\.08252465217209418\ \(0\)\
\-\ on\\:\\ 0\\.08106742842650944\ \(0\)\
\-\ focal\\:\\ 0\\.08027833713884477\ \(0\)\
\-\ edema\\:\\ 0\\.08004577251620691\ \(0\)\
\-\ performed\\:\\ 0\\.07939905575502876\ \(0\)\
\-\ of\\:\\ 0\\.07879289047690981\ \(0\)\
\-\ months\\:\\ 0\\.07812105990312511\ \(0\)\
\-\ due\\:\\ 0\\.07714640472761063\ \(0\)\
\-\ high\\:\\ 0\\.07627615260766266\ \(0\)\
\-\ evidence\\:\\ 0\\.07617777924029037\ \(0\)\
\-\ metastatic\\:\\ 0\\.0736074540652815\ \(0\)\
\-\ acute\\:\\ 0\\.07260246191403052\ \(0\)\
\-\ mri\\:\\ 0\\.06889148944701594\ \(0\)\
\-\ to\\:\\ 0\\.06710445707373891\ \(0\)\
\-\ male\\:\\ 0\\.05975544087586237\ \(0\)\
\-\ mass\\:\\ 0\\.051264625263386016\ \(0\)\
\-\ ct\\:\\ 0\\.051094995140792174\ \(0\)\
\-\ was\\:\\ 0\\.046773502819832884\ \(0\)\
\-\ or\\:\\ 0\\.04668925830381168\ \(0\)\
\-\ left\\:\\ 0\\.04578194743067737\ \(0\)\
\-\ with\\:\\ 0\\.026279989736731485\ \(0\)\
